# Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer

> **NCT00955890** · PHASE2 · TERMINATED · sponsor: **Fudan University** · enrollment: 12 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Dexrazoxane hydrochloride
- **DRUG:** Dexrazoxane hydrochloride

## Key facts

- **NCT ID:** NCT00955890
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Enrolled too slow
- **Last updated:** 2012-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955890, "Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00955890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*